Related MeSH Hierarchy (5)
Diseases [C] » Immune System Diseases [C20] » Purpura, Thrombocytopenic
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Signs and Symptoms » Skin Manifestations » Purpura » Purpura, Thrombocytopenic
Diseases [C] » Hemic and Lymphatic Diseases [C15] » Hematologic Diseases » Blood Coagulation Disorders » Purpura » Purpura, Thrombocytopenic
Diseases [C] » Hemic and Lymphatic Diseases [C15] » Hematologic Diseases » Blood Platelet Disorders » Thrombocytopenia » Thrombotic Microangiopathies » Purpura, Thrombocytopenic
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Hemorrhage » Purpura » Purpura, Thrombocytopenic
Description
Any form of purpura in which the PLATELET COUNT is decreased. Many forms are thought to be caused by immunological mechanisms. MeSH
Hierarchy View
Subtype Terms (2)
Purpura, Thrombocytopenic, Idiopathic
78 drugs (53 approved, 25 experimental)
Purpura, Thrombotic Thrombocytopenic
16 drugs (11 approved, 5 experimental)
Approved Indicated Drugs (2)
Phase 4 Indicated Drugs (2)
Phase 3 Indicated Drugs (1)
Phase 2 Indicated Drugs (3)
Organization Involved with Phase 4 Indications (20)
Organization Involved with Phase 3 Indications (90)
Allergy Associates of the Palm Beaches, North Palm Beach, FL
Allergy, Asthma & Immunology Assoc., Omaha, NE
Anhui College of Traditional Chinese Medicine
Assistance Publique - Hôpitaux de Paris
Asthma and Allergy Center, Papillion, NE
Capitol Comprehensive Cancer Care Clinic
Case Western Reserve University
Fundação de Amparo à Pesquisa do Estado de São Paulo
Gruppo Italiano Malattie EMatologiche dell'Adulto
Hamilton Health Sciences Corporation
National Heart, Lung, and Blood Institute (NHLBI)
Pediatric Allergy/Immunology Associates, Dallas, TX
People's Liberation Army of China
Sunshine Lake Pharma Co., Ltd.
Organization Involved with Phase 2 Indications (42)
China Academy of Chinese Medical Sciences
Etablissement Français du Sang
Fondazione Progetto Ematologia
Hematology and Oncology Specialists
Hospital Universitario Dr. Jose E. Gonzalez
Humanity & Health Research Centre
Icahn School of Medicine at Mount Sinai
Organization Involved with Phase 1 Indications (10)
Organization Involved with Other Experimental Indications (3)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
